What are the beneficial treatment strategies in maintaining T lymphocyte subsets after cancer surgery? A systematic review and network meta-analysis - Scorecard - MDSpire
Advertisement
What are the beneficial treatment strategies in maintaining T lymphocyte subsets after cancer surgery? A systematic review and network meta-analysis
Clinical Scorecard: Evaluating Effective Approaches for Preserving T Lymphocyte Subsets Post-Cancer Surgery: A Systematic Review and Network Meta-Analysis
At a Glance
Category
Detail
Condition
T lymphocyte subset preservation post-cancer surgery
Key Mechanisms
Impact of various treatment strategies on immune parameters
Target Population
Patients with solid tumors undergoing surgery
Care Setting
Perioperative management in cancer care
Key Highlights
IEN+NACT ranked highest for improving CD4+ counts
Top strategies include ERAS, TD, TEAS, and DEX
82 RCTs included in the analysis
Safety risks of top interventions deemed acceptable
Postoperative immunosuppression linked to tumor recurrence
Guideline-Based Recommendations
Diagnosis
Monitor T lymphocyte subsets as indicators of immune status
Management
Implement multimodal strategies including IEN+NACT, ERAS, TD, TEAS, and DEX
Monitoring & Follow-up
Evaluate CD3+, CD4+, CD8+ cells, and CD4+/CD8+ ratio postoperatively
Risks
Consider risks associated with perioperative interventions
Patient & Prescribing Data
Patients undergoing surgery for solid tumors
Combination therapies enhance immune function preservation
Clinical Best Practices
Utilize immune-enhanced enteral nutrition with neoadjuvant chemotherapy
Adopt Enhanced Recovery After Surgery protocols
Incorporate targeted therapies and specific anesthesia techniques
